Adeno-Associated Virus Site-Specific Integration and AAVS1 Disruption
Open Access
- 1 August 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (15) , 7874-7882
- https://doi.org/10.1128/jvi.78.15.7874-7882.2004
Abstract
Adeno-associated virus (AAV) is a single-stranded DNA virus with a unique biphasic lifestyle consisting of both a productive and a latent phase. Typically, the productive phase requires coinfection with a helper virus, for instance adenovirus, while the latent phase dominates in healthy cells. In the latent state, AAV is found integrated site specifically into the host genome at chromosome 19q13.4 qtr (AAVS1), the only animal virus known to integrate in a defined location. In this study we investigated the latent phase of serotype 2 AAV, focusing on three areas: AAV infection, rescue, and integration efficiency as a function of viral multiplicity of infection (MOI); efficiency of site-specific integration; and disruption of the AAVS1 locus. As expected, increasing the AAV MOI resulted in an increase in the percentage of cells infected, with 80% of cells infected at an MOI of 10. Additional MOI only marginally effected a further increase in percentage of infected cells. In contrast to infection, we found very low levels of integration at MOIs of less than 10. At an MOI of 10, at which 80% of cells are infected, less than 5% of clonal cell lines contained integrated AAV DNA. At an MOI of 100 or greater, however, 35 to 40% of clonal cell lines contained integrated AAV DNA. Integration and the ability to rescue viral genomes were highly correlated. Analysis of integrated AAV indicated that essentially all integrants were AAVS1 site specific. Although maximal integration efficiency approached 40% of clonal cell lines (essentially 50% of infected cells), over 80% of cell lines contained a genomic disruption at the AAVS1 integration locus on chromosome 19 (≈100% of infected cells). Rep expression by itself and in the presence of a plasmid integration substrate was able to mediate this disruption of the AAVS1 site. We further characterized the disruption event and demonstrated that it resulted in amplification of the AAVS1 locus. The data are consistent with a revised model of AAV integration that includes preliminary expansion of a defined region in AAVS1.Keywords
This publication has 63 references indexed in Scilit:
- AAV serotype 2 vectors preferentially integrate into active genes in miceNature Genetics, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2Journal of Virology, 2002
- Kinetics and Frequency of Adeno-Associated Virus Site-Specific Integration into Human Chromosome 19 Monitored by Quantitative Real-Time PCRJournal of Virology, 2002
- Efficient Integration of Recombinant Adeno-Associated Virus DNA Vectors Requires a p5- rep Sequence in cisJournal of Virology, 2002
- Phosphorylation of a Novel Myosin Binding Subunit of Protein Phosphatase 1 Reveals a Conserved Mechanism in the Regulation of Actin CytoskeletonJournal of Biological Chemistry, 2001
- Introduction of Single Base Substitutions at Homologous Chromosomal Sequences by Adeno-associated Virus VectorsMolecular Therapy, 2001
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Site-specific integration by adeno-associated virus: a basis for a potential gene therapy vectorGene Therapy, 1997
- The cryptic life style of adenoassociated virusBioEssays, 1995